2008Journal of Bengbu Medical CollegeRequires access

Analysis of antibiotic resistance of extended-spectrum β-lactamases-producing Escherichia coli strains

Shousong Zhao

Open publisher page 0 citations

Abstract

Objective:To study the resistance of the extended-spectrum β-lactamases(ESBLs)-producing Escherichia coli(E.coli) strains and to provide basis for clinical therapy.Methods:Agar dilution method was used to determine MICs of 13 antibiotics against 63 strains of ESBLs-producing E.coli which were collected between October 2005 and June 2006 in our hospital.Results:ESBLs-producing E.coli was generally sensitive to carbopenems and piperacillin/tazobatan,while most strains were highly resistant to piperacillin and quinolones.The rate of resistance to cefepime,ceforazone/sulbactam,ceftazidime,cefoxitin,ceftaxime and ceftriaxone were 34.92%,36.51%,44.45%,55.56%,82.54% and 84.13%,respectively.Conclusions:ESBLs-producing E.coli strains are highly resistant to antibiotics in our hospital.

About this research paper

What this paper is about

Objective:To study the resistance of the extended-spectrum β-lactamases(ESBLs)-producing Escherichia coli(E.coli) strains and to provide basis for clinical therapy.Methods:Agar dilution method was used to determine MICs of 13 antibiotics against 63 strains of ESBLs-producing E.coli which were collected between October 2005 and June 2006 in our hospital.Results:ESBLs-producing E.coli was generally sensitive to carbopenems and piperacillin/tazobatan,while most strains were highly resistant to piperacillin and quinolones.The rate of resistance to cefepime,ceforazone/sulbactam,ceftazidime,cefoxitin,ceftaxime and ceftriaxone were 34.92%,36.51%,44.45%,55.56%,82.54% and 84.13%,respectively.Conclusions:ESBLs-producing E.coli strains are highly resistant to antibiotics in our hospital.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To study the resistance of the extended-spectrum β-lactamases(ESBLs)-producing Escherichia coli(E.coli) strains and to provide basis for clinical therapy.Methods:Agar dilution method was used to determine MICs of 13 antibiotics against 63 strains of ESBLs-producing E.coli which were collected between October 2005 and June 2006 in our hospital.Results:ESBLs-producing E.coli was generally sensitive to carbopenems and piperacillin/tazobatan,while most strains were highly resistant to piperacillin and quinolones.The rate of resistance to cefepime,ceforazone/sulbactam,ceftazidime,cefoxitin,ceftaxime and ceftriaxone were 34.92%,36.51%,44.45%,55.56%,82.54% and 84.13%,respectively.Conclusions:ESBLs-producing E.coli strains are highly resistant to antibiotics in our hospital.

Key concepts: Cefepime, Cefoxitin, Sulbactam, Ceftazidime, Piperacillin, Microbiology, Cefoperazone, Escherichia coli

Related papers

Back to paper searchBrowse research topicsOriginal source
Analysis of antibiotic resistance of extended-spectrum β-lactamases-producing Escherichia coli strains — Research Paper | ScholarLens